
The U.S. Supreme Court on Thursday ruled a group of doctors lacked legal standing to challenge the Food and Drug Administration's regulation of the abortion pill mifepristone, preserving access to the medication nationwide.
The unanimous opinion was authored by Justice Brett Kavanaugh.
The case put abortion access back in the spotlight for the court after its conservative majority voted to overrule Roe v. Wade in 2022.